- $258.31m
- $244.49m
- $224.26m
- 99
- 75
- 49
- 88
Annual balance sheet for Viemed Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 31 | 28.4 | 16.9 | 12.8 | 17.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.4 | 14.7 | 15.4 | 18.5 | 24.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 47.2 | 47.3 | 39.7 | 38.4 | 52.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 55.1 | 62.8 | 68.4 | 76.9 | 79.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 113 | 118 | 117 | 155 | 177 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23 | 17.8 | 18.9 | 32.1 | 37.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.9 | 23.1 | 19.9 | 41 | 45.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 81.7 | 94.8 | 97.1 | 114 | 131 |
| Total Liabilities & Shareholders' Equity | 113 | 118 | 117 | 155 | 177 |
| Total Common Shares Outstanding |